EP2869841
Nýjar næmiörvunaráætlanir sem innihalda ónæmisvaldandi fjölpeptíð kóðuð af fjölkirnum
Status:
EP Einkaleyfi ógilt eftir andmæliEP appl. date:
5.7.2013EP published:
25.8.2021EP application number:
13734111.1
EP translation filed:
2.11.2021Grant published:
15.12.2021EPO information:
European Patent Register
Max expiry date:
4.7.2033Expiry date:
4.7.2025
Title:
NOVEL PRIME-BOOSTING REGIMENS INVOLVING IMMUNOGENIC POLYPEPTIDES ENCODED BY POLYNUCLEOTIDES
Timeline
Today
5.7.2013EP application
25.8.2021EP Publication
2.11.2021Translation submitted
15.12.2021Registration published
4.7.2025Expires
Owner
Name:
GlaxoSmithKline Biologicals SAAddress:
Rue de l'Institut 89, 1330 Rixensart, BE
Inventor
Name:
NICOSIA, AlfredoAddress:
80123 Naples, IT
Name:
CORTESE, RicardoAddress:
1330 Rixensart, BE
Name:
VITELLI, AlessandraAddress:
00152 Rome, IT
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
PCT/EP2012/063196Date:
5.7.2012Country:
WO
Classification
Categories:
A61K 39/155, C12N 15/861, C12N 15/863, C07K 16/44
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 21.6.2022
Expires: 4.7.2023
Payer: Patice ehf.
Number: 11
Paid: 22.6.2023
Expires: 4.7.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 19.6.2024
Expires: 4.7.2025
Payer: Árnason Faktor ehf.